Wadsworth Center

Last updated
Motto Science in the pursuit of health
Established1901
Research typePublic health
Director Dr Leonard Peruski
Faculty 100
Staff 1000
Address Empire State Plaza
Location Albany, New York
42°38′56″N73°45′36″W / 42.648877°N 73.760037°W / 42.648877; -73.760037
12237
Operating agency
New York State Department of Health
Website www.wadsworth.org

The Wadsworth Center, located in Albany, New York, is the research-intensive public health laboratory of the New York State Department of Health. [1]

Contents

History

The Wadsworth Center, originally the New York State's Antitoxin Laboratory, was established in 1901. Its mission was to standardize and manufacture antitoxin, which was for the treatment of communicable diseases such as diphtheria and anthrax. In 1914, the Antitoxin Laboratory was designated the Division of Laboratories and Research. At the same time, Augustus B. Wadsworth was named director and he served until 1945. [2]

In 1974, Enzo Paoletti joined the Wadsworth Center and with Dennis Panicali devised a strategy to produce DNA vaccines by using genetic engineering to transform ordinary smallpox vaccine into vaccines that may be able to prevent other diseases. [3] In four seminal papers they provided the technology and proof of principle to construct vaccines using genetically engineered poxviruses, altering the DNA of cowpox virus by inserting a gene from other viruses, namely Herpes simplex virus, hepatitis B and influenza. [4] [5] [6] [7]

Today

The Wadsworth Center has over 100 principal investigators and more than 1,000 staff in five locations, the Biggs Laboratory (at the Empire State Plaza), the David Axelrod Institute (on New Scotland Avenue), the Center for Medical Science, Western Avenue and, in nearby Guilderland, New York, the Griffin Laboratory. [8] [9] Scientists at the Wadsworth Center study public health issues, such as drug resistance to emerging infections, environmental exposures, and basic biological processes that contribute to human health and disease. Additionally, as the state's public health reference laboratory, the Wadsworth Center is responsible for responding to public health threats, developing methods to detect microbes and genetic disorders, measuring and analyzing environmental chemicals, and licensing clinical and environmental laboratories. In conjunction with the University at Albany, SUNY, the Wadsworth Center has training programs for undergraduates, graduates, and postdoctoral fellows.

Notes and references

  1. Wadsworth Center. "Mission - Wadsworth Center, NYS Department of Health" . Retrieved 2008-10-15.
  2. Wadsworth Center. "History of Wadsworth Center" . Retrieved 2008-10-15.
  3. White LO, Gibb E, Newham HC, Richardson MD, Warren RC (July 1979). "Comparison of the growth of virulent and attenuated strains of Candida albicans in the kidneys of normal and cortison-treated mice by chitin assay". Mycopathologia. 67 (3): 173–7. doi:10.1007/bf00470753. PMID   384256. S2CID   31914107.
  4. Nakano E, Panicali D, Paoletti E (March 1982). "Molecular genetics of vaccinia virus: demonstration of marker rescue". Proceedings of the National Academy of Sciences of the United States of America. 79 (5): 1593–6. Bibcode:1982PNAS...79.1593N. doi: 10.1073/pnas.79.5.1593 . PMC   346021 . PMID   6951197.
  5. Panicali D, Paoletti E (August 1982). "Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus". Proceedings of the National Academy of Sciences of the United States of America. 79 (16): 4927–31. Bibcode:1982PNAS...79.4927P. doi: 10.1073/pnas.79.16.4927 . PMC   346798 . PMID   6289324.
  6. Panicali D, Davis SW, Weinberg RL, Paoletti E (September 1983). "Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin". Proceedings of the National Academy of Sciences of the United States of America. 80 (17): 5364–8. Bibcode:1983PNAS...80.5364P. doi: 10.1073/pnas.80.17.5364 . PMC   384256 . PMID   6310573.
  7. Paoletti E, Lipinskas BR, Samsonoff C, Mercer S, Panicali D (January 1984). "Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D". Proceedings of the National Academy of Sciences of the United States of America. 81 (1): 193–7. Bibcode:1984PNAS...81..193P. doi: 10.1073/pnas.81.1.193 . PMC   344637 . PMID   6320164.
  8. Wadsworth Center. "By the Numbers - Wadsworth Center, NYS Department of Health" . Retrieved 2008-10-15.
  9. Wadsworth Center. "Contact Information - Phone Numbers and Mailing Addresses - Wadsworth Center, NYS Department of Health" . Retrieved 2008-10-15.

Related Research Articles

<span class="mw-page-title-main">DNA vaccine</span> Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

A bacterial artificial chromosome (BAC) is a DNA construct, based on a functional fertility plasmid, used for transforming and cloning in bacteria, usually E. coli. F-plasmids play a crucial role because they contain partition genes that promote the even distribution of plasmids after bacterial cell division. The bacterial artificial chromosome's usual insert size is 150–350 kbp. A similar cloning vector called a PAC has also been produced from the DNA of P1 bacteriophage.

<span class="mw-page-title-main">Vaccinia</span> Strain of poxvirus

Vaccinia virus is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, which encodes approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5–10 fg. The vaccinia virus is the source of the modern smallpox vaccine, which the World Health Organization (WHO) used to eradicate smallpox in a global vaccination campaign in 1958–1977. Although smallpox no longer exists in the wild, vaccinia virus is still studied widely by scientists as a tool for gene therapy and genetic engineering.

<i>Poxviridae</i> Family of viruses

Poxviridae is a family of double-stranded DNA viruses. Vertebrates and arthropods serve as natural hosts. There are currently 83 species in this family, divided among 22 genera, which are divided into two subfamilies. Diseases associated with this family include smallpox.

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune system responses. Oncolytic viruses also have the ability to affect the tumor micro-environment in multiple ways.

<span class="mw-page-title-main">Herpes simplex virus</span> Species of virus

Herpes simplex virus1 and 2, also known by their taxonomical names Human alphaherpesvirus 1 and Human alphaherpesvirus 2, are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Both HSV-1 and HSV-2 are very common and contagious. They can be spread when an infected person begins shedding the virus.

<span class="mw-page-title-main">Gene delivery</span> Introduction of foreign genetic material into host cells

Gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells. Gene delivery must reach the genome of the host cell to induce gene expression. Successful gene delivery requires the foreign gene delivery to remain stable within the host cell and can either integrate into the genome or replicate independently of it. This requires foreign DNA to be synthesized as part of a vector, which is designed to enter the desired host cell and deliver the transgene to that cell's genome. Vectors utilized as the method for gene delivery can be divided into two categories, recombinant viruses and synthetic vectors.

<span class="mw-page-title-main">EIF3M</span> Protein-coding gene in the species Homo sapiens

Eukaryotic translation initiation factor 3, subunit M (eIF3m) also known as PCI domain containing 1 (herpesvirus entry mediator) (PCID1), is a protein that in humans is encoded by the EIF3M gene.

Anthony (Tony) Charles Minson, PhD, FMedSci is a British virologist known for his work on the biology of herpesviruses, and a university administrator. He was the Senior Pro-Vice-Chancellor of the University of Cambridge from 2003 to 2009. He is emeritus professor of virology at the university's Department of Pathology and an emeritus fellow of Wolfson College.

<span class="mw-page-title-main">Herpes simplex</span> Viral disease caused by herpes simplex viruses

Herpes simplex is a viral infection caused by the herpes simplex virus. Infections are categorized based on the part of the body infected.

Enzo Paoletti was an Italian-American virologist who developed the technology to express foreign antigens in vaccinia and other poxviruses. This advance led to the development of vaccines against multiple disease-causing pathogens.

<span class="mw-page-title-main">Genetically modified virus</span> Species of virus

A genetically modified virus is a virus that has been altered or generated using biotechnology methods, and remains capable of infection. Genetic modification involves the directed insertion, deletion, artificial synthesis or change of nucleotide bases in viral genomes. Genetically modified viruses are mostly generated by the insertion of foreign genes intro viral genomes for the purposes of biomedical, agricultural, bio-control, or technological objectives. The terms genetically modified virus and genetically engineered virus are used synonymously.

Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development, vaccines and genome editing. HSV-1 and HSV-2 are commonly thought of as oral and genital herpes respectively, but other members in the herpes family include chickenpox (varicella/zoster), cytomegalovirus, and Epstein-Barr virus. There are many more virus members that infect animals other than humans, some of which cause disease in companion animals or have economic impacts in the agriculture industry.

<span class="mw-page-title-main">José Esparza</span> Venezuelan-American virologist

José Esparza is a Venezuelan American virologist who lives in the USA. He is known for his efforts to promote the international development and testing of vaccines against HIV/AIDS. During 17 years he pursued an academic career at the Venezuelan Institute for Scientific Research (IVIC), attaining positions as full professor of virology and chairman of its Department of Microbiology and Cell Biology. From 1986 to 2014 he worked continuously as a viral vaccine expert and senior public health adviser for international health policy agencies such as the World Health Organization, the Joint United Nations Programme on HIV/AIDS, and the Bill & Melinda Gates Foundation. José G. Esparza is currently an adjunct professor of medicine, at the Institute of Human Virology. During 2016 he was the president of the Global Virus Network. In the context of historical studies on the early use of horsepox for smallpox vaccination, Esparza was appointed in 2018 as a Robert Koch Fellow at the Robert Koch Institute in Berlin, Germany. He is an active member of the Latin American Academy of Sciences, ACAL.

David Mahan Knipe is the Higgins Professor of Microbiology and Molecular Genetics in the Department of Microbiology at the Harvard Medical School in Boston, Massachusetts and co-chief editor of the reference book Fields Virology. He returned to the Chair of the Program in Virology at Harvard Medical School in 2019, having previously held the position from 2004 through 2016 and served as interim Co-Chair of the Microbiology and Immunobiology Department from 2016 through 2018.

Roselyn J. Eisenberg is a professor at The University of Pennsylvania and a member of the University's School of Veterinary Medicine and School of Dental Medicine. The majority of Eisenberg's research is focused on the herpes simplex virus and the poxvirus and how they enter into susceptible cells. She also studies glycoproteins, vaccines, virology and microbiology.

Raccoonpox virus (RCN) is a double-stranded DNA virus and a member of the orthopoxviruses in the family Poxviridae and subfamily Chordopoxvirinae which consists of eight genera: Avipoxvirus, Capripoxvirus, Leporipoxvirus, Molluscipoxvirus, Orthopoxvirus, Parapoxvirus, Suipoxvirus and Yatapoxvirus Vertebrates are the natural host of Chordopoxvirinae subfamily viruses. More specifically, raccoons are the natural hosts of RCN. RCN was isolated in 1961 from the upper respiratory tissues of 2 raccoons in a group of 92 observably healthy raccoons trapped close to Aberdeen, Maryland.

B13R is a protein expressed by vaccinia virus.

Peter Maxwell Howley is an American pathologist, virologist, and professor at Harvard Medical School. He has been president of the American Society for Virology and the American Society for Investigative Pathology and a co-editor of the Annual Review of Pathology: Mechanisms of Disease.

<span class="mw-page-title-main">Viral vector vaccine</span> Type of vaccine

A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.